ACAD ACADIA Pharmaceuticals Inc.
$21.23
ACADIA Pharmaceuticals Inc. (ACAD) Earnings News
Earnings press releases, previews and reviews for ACADIA Pharmaceuticals Inc. (ACAD), newest first. Our most recent is review: Acadia Beats as DAYBUE Acceleration Runs Into a Bruised Pipeline Story.
Wednesday
November 4, 2026
6:56 PM ET
Acadia Beats as DAYBUE Acceleration Runs Into a Bruised Pipeline Story
Earnings Whispers · Review
Wednesday
November 4, 2026
4:05 PM ET
Acadia Pharmaceuticals Reports Third Quarter 2026 Financial Results
Tuesday
October 27, 2026
3:11 PM ET
ACADIA's Rising Revenue Story Meets a Battered Stock as Nuplazid's Second-Half Ramp Faces Its Test
Earnings Whispers · Preview
Wednesday
October 21, 2026
4:05 PM ET
Acadia Pharmaceuticals to Announce Third Quarter 2026 Financial Results on November 4, 2026
Tuesday
August 4, 2026
4:05 PM ET
Acadia Pharmaceuticals Reports Second Quarter 2026 Financial Results
Wednesday
July 15, 2026
4:05 PM ET
Acadia Pharmaceuticals to Announce Second Quarter 2026 Financial Results on August 4, 2026